Brokerages Set Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Price Target at $18.14
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the […]